Online Pharmacy US

The first prospective trial specifically designed to evaluate erectile function in ED patients with dyslipidemia

CHICAGO, Dec. 10 (HSMN NewsFeed) — Results of the first prospective trial specifically designed to evaluate erectile function in erectile… BiopharmaceuticalsSchering-Plough, erectile dysfunction, LEVITRA, vardenafil, dyslipidemia (Source: HSMN NewsFeed)

Results of the first prospective trial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse. These data were presented at the Sexual Medicine Society of North America (SMSNA) Fall Meeting held in (more…)

New study presented for the treatment of ere ctile dysfunction
Levitra
-Therapy suitable for men with High Cholesterol Additional study
with Testogel verifies improvement of quality of life through
testosterone therapy
MILAN, BERLIN, March… (Source: Drugs.com – Clinical Trials)

MedWorm Message: Register forMedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

The first prospective trial specifically designed to evaluate erectile function in ED patients with dyslipidemia

CHICAGO, Dec. 10 (HSMN NewsFeed) — Results of the first prospective trial specifically designed to evaluate erectile function in erectile… BiopharmaceuticalsSchering-Plough, erectile dysfunction, LEVITRA, vardenafil, dyslipidemia (Source: HSMN NewsFeed)

Results of the first prospective t rial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse. These data were presented at the Sexual Medicine Society of North America (SMSNA) Fall Meeting held (more…)